Dr. Pavel Stodulka – Czech Republic
“Acriva Trinova is a great addition to the trifocal family. According to my initial experience, it looks like Acriva Trinova really tolerates ametropia or at least low myopia better than other trifocal lenses. In addition to that, it provides continuous vision at all distances.
Congratulations to the VSY R&D team! I have already implanted Acriva Trinova in many patients, and I will present the results at the ESCRS Winter Meeting in Belgrade, Serbia.”
Prof. Dr. Ewa Mrukwa-Kominek – Poland
Acriva Trinova offers easy implantation, good centration, stable positioning and high patient satisfaction with distance, intermediate and near visual acuity as well as all the distances in between. I will confidently continue implanting this lens in my patients and share the post-op results at the upcoming congresses.
Dr. Marko Hawlina – Slovenia
“I was very curious about the principles of Trinova sinusoidal design and how it would perform. Now that the initial patients have been implanted, I have no doubt that this new concept works very well. In all, unaided distance vision was 0.8-1.0. Near vision was clear from 40 cm up to appx. 50-80 cm for comfortable computer work. Wavefront measurements on Nidek OPD III showed excellent point spread function. I also liked that, at the slit lamp, the concentric rings are almost invisible.”
Prof. Dr. Giovanni Alessio – Italy
“My first impression of Acriva Trinova is that it provides excellent seamless vision with comfortable reading distances.
My patients are very happy after the surgery. The post-op results were as good as expected.”
Gregory Carbonez – Belgium
Trifocal IOL with Sinusoidal Optical Surface Profile
Traditional trifocal IOLs exhibit sharp-edged diffractive rings. The angular transition between the concentric diffractive rings causes a loss in the transmission of light and undesired light refractions. The design of the lens surface is responsible for the main disadvantages of a diffractive lens. With Acriva Trinova’s Sinusoidal Vision Technology (SVT), VSY Biotechnology manages to lead the surface design toward a sinusoidal pattern.
50% less light loss
Traditional IOLs with sharp diffractive steps at the surface provide 80% to 85% light transmission. Thus, depending on the type of diffractive lens, the loss of light energy varies between 15% and 20%. Acriva Trinova offers 92% light transmission, decreasing the light loss to 8%. The new sinusoidal optical surface therefore results in about 50% less light loss than traditional diffractive lenses. Better light transmission reduces energy loss, which directly improves contrast sensitivity.
Optimizing visual comfort
Because of developments in the field of multimedia communication, close-up tasks are no longer limited to reading newspapers or notices; they now extend to the use of tablets, smartphones, e-books, laptops and desktops. These new daily activities require near vision and intermediate vision of 30 cm to 75 cm. Acriva Trinova has an effective depth of focus of 38 cm to 80 cm, offering the ideal solution for the active person who wants to be completely free of glasses in all activities.
The new generation of diffractive lenses
With this innovative trifocal lens, refractive lens exchange (RLE) and cataract treatments are crossing a new threshold of quality. The fundamentally new sinusoidal design of the lens surface provides more benefits and less inconvenience. Is Acriva Trinova the first of a new generation of diffractive lenses? The future will tell. In any case, this particularly user-friendly diffractive IOL is very promising.
Dr. Yusuke Tanabe – Japan
“Acriva Trinova IOL is a diffractive trifocal IOL with original advanced optical design technology named Seamless Vision Technology (SVT). The IOL can provide a continuous clear vision area from near to distance, and the IOL can also improve typical weak points of diffractive trifocal IOLs such as high light loss and low contrast sensitivity. After learning their technology, I made immediate contact with VSY Biotechnology BV to introduce the IOL to my patients.
Although, as the first to introduce the IOL in Japan, I have started to introduce the IOL to my patients gradually with extreme care and careful consultation, the initial clinical outcomes have been promising, and the IOL has received impressive satisfaction ratings from my patients.”
Dr. Miguel Ángel Gil Arnal – Spain
“My first impression of the AcrivaUD Trinova IOL implant is that it is an easy-to-load lens. The protection of the injector plunger prevents imprints on the lens. The unfolding of the lens is smooth, and the sinusoidal rings are perfectly visualized in the microscope with a clearly different pattern than the rings of other diffractive lenses.”
Dr. Santiago Martínez-Zárate – Colombia
“Whenever I am going to implant a trifocal lens, I spend a good part of the consultation explaining to the patient about the possibility of experiencing halos. For the past few months, I have been implanting Acriva Trinova, and at postoperative checkups, I ask patients about their vision, and they tell me they do not see halos at all. It has been rewarding not only for the patient but also for me to see tremendous results.”
Pichit Naripthaphan, MD – Thailand
“I’ve been implanting the new Sinusoidal Acriva Trifocals for more than a year. You’ll be surprised that you can hardly find the steps on the IOL on the slit lamp examination on postoperative day. That can translate into almost no glare or halo. The EDOF characteristic of the IOL makes Trinova tolerate slight tilts and slightly off refractive targets. Some of my patients end up with -0.5D, but UCVA at distance is still 20/20 or even 20/16 with full range of vision.
Dr. Georgios Kontadakis – Greece
“I had always been very reluctant towards multifocal intraocular lenses because of halo and glare phenomena, which bother patients a lot, especially those that drive at night. I was delighted to confirm that patients with Acriva Trinova are minimally bothered by such phenomena. Driving in all circumstances is a predominant habit in patients where I work, and Acriva Trinova is a reliable solution for continuous vision at near, intermediate and far distances for our patients.
The intraoperative OCT has shown that Trinova optic is almost in close contact with the posterior capsule, much more than any other multifocal IOL, implying that the ELP is very accurate and there may be less PCO. No wonder Trinova is my definite choice for multifocal IOL.”
Dr. Jérôme Bovet – Switzerland
“The new sinusoidal trifocal IOL, Acriva Trinova, provides excellent visual outcomes at all distances, even in mesopic conditions. The new design minimizes dysphotopsia and tolerates post-op minor refractive errors. I strongly recommend Acriva Trinova to my patients who want to have a spectacle-free life.”
Dr. Andra Bedei – Italy
“I implanted this lens in 20 eyes of 10 patients with cataracts. I studied the UCDVA, BCDVA, BCNVA, UCNVA, contrast sensitivity and the presence of glare and halos, pre-op and one month post-op. The results showed excellent visual outcomes with minimal disturbances. I appreciated the sinusoidal trifocal Acriva Trinova lens a lot.”
Dr. Jan Witkiewicz – Poland
“My first experience with Trinova was in clear lens exchange performed in both myopic eyes of a 47-year-old female patient. Though preoperatively her BCVA was 0,8-0,9 (-5,50 D sph), her post-op UCVA is 1,1! She came for a second post-op control (three days after surgery) driving her own car 120 km and expressing her satisfaction: “I wasn’t able to see the license plates of cars before surgery. Now I see clearly at all distances.”
Dr. Francisco Poyales – Spain
“Surgery without incidents. Very easy implantation by 2.2 mm incision. UCVA post-surgery (1 day) was 0.9. But above all, the patient was very happy with his vision. The second eye will follow shortly.”
Dr. Minoru Tomita – Japan
“Most of my patients have high myopia. I even implanted 0.0 D Acriva Trinovia. The patient satisfaction and the results are very good. I believe we can target high myopia patients as well as low myopia cases with this sinusoidal trifocal IOL. Also, with this lens, I don’t receive any complaints from my patients about halo and glare.”
Dr. Anagha Heroor – India
“I have used the Acriva Trinova trifocal lens recently and have found the results to be extremely gratifying. The loading and implantation is easy and smooth. The patient had 6/6 vision post-op with comfortable distance, intermediate and near vision without any complaints of glare or halos. I am extremely satisfied with the results of the lens. Looking forward to using this lens more often.’’
Masanori Hangai – Japan
Acriva Trinova has my favorite beautiful sinusoidal surface shape, which I expected to have less halo and glare. I have already implanted Acriva Trinova in many patients and found it resulted in no glare and less halo than expected. I also found that Acriva Trinova satisfactorily provided continuous vision at all distances. In addition, Acriva Trinova offers easy surgical implantation, good postoperative centration and tolerance of postoperative IOL tilts. Thus, Acriva Trinova is for sure the best candidate for my patients.
Dr. Siddharth Karan – India
“Since it is the first and only lens with Sinusoidal Vision Technology, my patient did not experience any glare. This is of great importance as my patient is an NRI (Non-resident Indian) from the US, and driving is mandatory there. She is very satisfied and has referred her contacts to me.
It is remarkably smooth to implant and very easy to fold and implant into the bag, even in small rhexis.
One month post-op, the patient is very satisfied with the result: 6/5 both eyes and with excellent intermediate vision. There are no glare or halos, even during nighttime driving. All in all, a truly excellent lens and highly recommended. Congratulations on this great product.’’
Dr. Petra Schollmayer – Slovenia
“My initial personal experience with Trinova has been very good. My first six patients reported good vision at all distances, with best near vision at approximately 40 cm. They also had surprisingly good near visual acuity in a dim environment. The visual performance, although good already on the first day, improved additionally over the next days, reaching 1.0 and J2 unaided. Insertion was easy, and the lens was well centered in all cases. This IOL provides comfortable vision at all distances with less adverse visual phenomena than conventional diffractive IOLs.”
Dr. Roberto Bellucci – Italy
“Multifocal lenses often provide glare, halos and other optical disturbances. The Acriva Trinova lens is designed for spectacle independency and provides distance vision, intermediate vision and good near vision without such problems. My patients never complain about dysphotopsia, halos and glare. They simply like their vision.”
Dr. Johan Blanckaert – Belgium
“VSY Biotechnology has introduced AcrivaUD Trinova, the new trifocal IOL, with great success. AcrivaUD Trinova trifocal IOL manages to give my patients true continuous vision in their most needed range. It is very well accepted by my patients, and I am now confident to offer this trifocal IOL to a broader group, like myopic and emmetropic patients.”
Dr. Tomasz Goździewicz – Poland
“Our results confirm very good tolerance of this new sinusoidal trifocal IOL, Acriva Trinova, and a quality of vision without spectacles that meets the expectations of the most demanding patients. Implantation of the AcrivaUD Trinova enables distance, near, and intermediate vision, without the need for spectacles. Our experience has shown fast neuroadaptation, ease of implantation, safety and predictability of results, ensuring a high level of satisfaction in patients of all ages. These excellent results encourage wider use of the trifocal intraocular lens Acriva Trinova.”
Dr. Dimitra M. Portaliou – Greece
“After performing one of the first implantations of the Acriva Trinova trifocal IOL in Greece on a young patient (~40 years old) with cataract, I am confident in saying that Acriva Trinova technology allowed my patient to have spectacle-free vision at all distances without any concerns. The implantation of the Trinova IOL was surgically easy and straightforward to perform. I will continue to use the Acriva Trinova trifocal intraocular lenses in my practice as they represent a safe and high-quality choice for my patients.”
Dr. Daniel Elies – Spain
During the surgery, the new IOL Acriva Trinova performed very nicely. The loading and folding into the cartridge did not present any major difficulty. The IOL moves forward during the injection in a very controlled way, and the introduction into the anterior chamber was very smooth.
This new IOL seems to be less rigid than other plate-haptic acrylic lenses but at the same time very stable once positioned in the capsular bag. Also, the diffractive structures seem to be less sharp than other IOLs, having a smoother transition which makes me think that it can indeed reduce dysphotopsia or other unwanted phenomena.
Dr. Jaime Vasquez – Chile
“It’s a very smooth lens and easy to implant.
It was great to see the sinusoidal pattern under the microscope. Even in just a few days post-op, the outcome seems to be excellent. The patient now has a better life quality due to spectacle independence.”
Dr. Mohammad Abu Al-Dabaat – Jordan
“My first experience with Acriva Trinova IOL was with a post Lasik patient (which is not the ideal case for Trifocal IOLs). Surprisingly, with Acriva Trinova, the patient’s vision is great for near and intermediate distance. No glare, no halos, and great night vision
Dr. Clayton Erasmus – South Africa
“I have not found a more forgiving trifocal IOL than the AcrivaUD Trinova. My patients are extremely happy with the visual acuity achieved at all distances of focus. The plate-haptic provides superior stability in the bag with excellent centration, and the lens loading and insertion are very easy. It looks beautiful in the eye with its unique sinusoidal waves. I am extremely happy with what I have experienced with this amazing lens technology.”